Table 2.
Maternal fat depots weight at 19dG.
C | Cres | MO | MOres | |
---|---|---|---|---|
Body weight (g) | 452 ± 7 | 429 ± 8 | 537 ± 14 * | 514 ± 16 * |
Total fat (g) | 20.3 ± 2.4 | 12.4 ± 1 | 56.5 ± 5.5 * | 50.7 ± 4.9 * |
Adiposity index | 4.5 ± 0.5 | 2.9 ± 0.3 | 10.5 ± 1 * | 9.8 ± 0.9 * |
Fat depot (g) | ||||
Mediastinal | 0.3 ± 0.07 | 0.3 ± 0.03 | 3.8 ± 2.7 | 1 ± 0.2 |
Retroperitoneal and perirenal | 3.4 ± 0.5 | 2.7 ± 0.2 | 14.5 ± 1.2 * | 14.1 ± 1.2 * |
Omental | 3.8 ± 0.5 | 3.9 ± 0.6 | 15.6 ± 3.2 * | 13.6 ± 2.1 * |
Parametrial and perivescical | 4.3 ± 0.8 | 2.9 ± 0.2 | 11.9 ± 1.2 * | 11.8 ± 1.3 * |
Periovarian | 2.8 ± 0.3 | 2.6 ± 0.3 | 10.8 ± 0.6 * | 10.1 ± 0.8 * |
Mean ± SEM, (C: control, n = 8; Cres: control + resveratrol, n = 10; MO: maternal obesity, n = 7; MOres: maternal obesity + resveratrol, n =7), * p < 0.05 vs their respective control. dG: days of gestation. No differences were observed between C and Cres and MO and MOres, and no interactions were observed between maternal diet and resveratrol supplementation.